Two-Year Results of Intravitreal Ranibizumab in Patients with Myopic Choroidal Neovascularization

被引：0
|
作者：
Shchuko, Andrey G. [1 ]
Zaytseva, Natalya V. [1 ]
Zlobin, Igor V. [1 ]
机构：
[1] S Fyodorov Eye Microsurg Fed State Inst, Irkutsk Branch, Irkutsk, Russia
来源：
OPHTHALMOLOGICA | 2014年 / 232卷
关键词：
Myopic CNV; Ranibizumab;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
48
引用
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [21] MICROPERIMETRIC RETINAL CHANGES IN MYOPIC CHOROIDAL NEOVASCULARIZATION TREATED WITH INTRAVITREAL RANIBIZUMAB
    Varano, Monica
    Tedeschi, Massimiliano
    Oddone, Francesco
    Perillo, Loredana
    Coppe, Andrea Maria
    Parravano, Mariacristina
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2010, 30 (03): : 413 - 417
  • [22] TWO-YEAR OUTCOMES OF INTRAVITREAL BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN JAPANESE PATIENTS WITH PATHOLOGIC MYOPIA
    Hayashi, Kengo
    Shimada, Noriaki
    Moriyama, Muka
    Hayashi, Wakako
    Tokoro, Takashi
    Ohno-Matsui, Kyoko
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2012, 32 (04): : 687 - 695
  • [23] Comparison of Intravitreal Aflibercept and Ranibizumab for Treatment of Myopic Choroidal Neovascularization: One-Year Results-A Retrospective, Comparative Study
    Erden, Burak
    Bolukbasi, Selim
    Bas, Emine
    Cakir, Akin
    JOURNAL OF OPHTHALMOLOGY, 2019, 2019
  • [24] Optical coherence tomography angiography in myopic choroidal neovascularization after intravitreal ranibizumab
    Cennamo, Gilda
    Amoroso, Francesca
    Schiemer, Stefano
    Velotti, Nunzio
    Alfieri, Mariacristina
    de Crecchio, Giuseppe
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2019, 29 (02) : 239 - 243
  • [25] Effect of intravitreal injection of aflibercept or ranibizumab on chorioretinal atrophy in myopic choroidal neovascularization
    Sayanagi, Kaori
    Uematsu, Sato
    Hara, Chikako
    Wakabayashi, Taku
    Fukushima, Yoko
    Sato, Shigeru
    Ikuno, Yasushi
    Nishida, Kohji
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 257 (04) : 749 - 757
  • [26] Effect of intravitreal injection of aflibercept or ranibizumab on chorioretinal atrophy in myopic choroidal neovascularization
    Kaori Sayanagi
    Sato Uematsu
    Chikako Hara
    Taku Wakabayashi
    Yoko Fukushima
    Shigeru Sato
    Yasushi Ikuno
    Kohji Nishida
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2019, 257 : 749 - 757
  • [27] Short-term efficacy and safety of intravitreal ranibizumab for myopic choroidal neovascularization
    Silva, Rufino M.
    Ruiz-Moreno, Jose M.
    Nascimento, Joao
    Carneiro, Angela
    Rosa, Paulo
    Barbosa, Augusto
    Carvalheira, Fausto
    Abreu, J. Rui Faria
    Cunha-Vaz, Jose G.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2008, 28 (08): : 1117 - 1123
  • [28] A new treatment algorithm for the management of myopic choroidal neovascularization using intravitreal ranibizumab
    Iacono, Pierluigi
    Parodi, Maurizio Battaglia
    Papayannis, Alexandros
    La Spina, Carlo
    Varano, Monica
    Bandello, Francesco
    ACTA OPHTHALMOLOGICA, 2015, 93 (06) : E519 - E520
  • [29] Intravitreal Ranibizumab for Myopic Choroidal Neovascularization: 12 Months Follow-Up
    Papayannis, A.
    Kontadakis, D.
    Parodi, M. Battaglia
    Iacono, P.
    Sheeth, S.
    Cascavilla, M.
    Menchini, F.
    Bandello, F.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [30] Prognostic Factor for Visual Outcomes Two-Years after Intravitreal ranibizumab for Myopic Choroidal Neovascularization
    Nakanishi, Hideo
    Tsujikawa, Akitaka
    Yamashiro, Kenji
    Oishi, Akio
    Ooto, Sotaro
    Tamura, Hiroshi
    Yoshimura, Nagahisa
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
12345